about
Histoplasmosis infections worldwide: thinking outside of the Ohio River valleySeroprevalence of histoplasmosis in Kampala, UgandaUnmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation.Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohortsCentral nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency VirusMethods of rapid diagnosis for the etiology of meningitis in adultsStandardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings.Accuracy of noninvasive intraocular pressure or optic nerve sheath diameter measurements for predicting elevated intracranial pressure in cryptococcal meningitis.Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal MeningitisRespiratory Failure due to Possible Donor-Derived Sporothrix schenckii Infection in a Lung Transplant Recipient.Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal MeningitisHuman Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding.Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda.Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF.Illuminating meningococcal diagnosis with LAMPGeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last.Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitisEfficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.Diagnostic Delay and Antibiotic Overuse in Acute Pulmonary Blastomycosis.Central nervous system immune reconstitution inflammatory syndrome.Unmasking Cryptococcal Meningitis Immune Reconstitution Inflammatory Syndrome due to Granulocyte Colony-Stimulating Factor Use in a Patient with a Poorly Differentiated Germ Cell NeoplasmHistoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management.Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitisSeroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya.Eosinophilic Meningitis Due to Infection With Paragonimus kellicotti.The Effect of Structural Violence on Patients with Sickle Cell Disease.Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.Rapid access to comprehensive care may explain better outcomes in persons with sepsis with solid organ transplant versus those without solid organ transplant.A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis.1,3-β-D-glucan in cryptococcal meningitis.Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda.Absence of Cerebrospinal Fluid Pleocytosis in Tuberculous Meningitis is a Common Occurrence in HIV Co-infection and a Predictor of Poor Outcomes.1468Detection of High CSF Levels of (1 → 3)-Beta-D-Glucan in Cryptococcal Meningitis.Xpert Ultra's place in the diagnosis of tuberculous meningitis - Authors' reply.Cutaneous infection with Mycobacterium fortuitum after subcutaneous injection of human chorionic gonadotropin.1703Delta-like 1 ligand (DLL) measurement in cerebrospinal fluid for detection of Mycobacterium tuberculosis meningitis.Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitisCan improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in UgandaReview of Fran Quigley, Walking Together, Walking Far
P50
Q30377989-B1D8F011-611F-43C2-8111-3DD8CD171DF4Q30380987-4BE2C86C-496C-4C48-9FCD-7C0A96341EADQ33765829-2DAAF1B8-6553-4748-B07E-7D8606E46FD7Q33792332-71978564-D5A6-47CB-B5EE-6674BE3E3634Q34436150-6B4AC734-8F6A-4FE7-BCC7-26CD4B13BC8BQ34554521-E8FA9B99-B281-466A-8CCF-6B6ED4B18020Q34801921-9D123006-390F-4016-8C17-6906BA027090Q35072051-B20DE3E5-E968-4FFE-BC5A-311D10CCEE80Q35072106-0763056C-2A78-4455-AC02-BF3FD8921524Q36366833-709E5C2A-ACDB-469E-ADED-5F14DD14FE2CQ36463811-8E9C1266-99A6-4621-A3FB-961109363A07Q36488971-CA062773-1841-4AC9-A030-0CE7FB29148BQ36609745-B9F6DB13-E5F3-489C-B9A3-011927C19545Q36622358-882CEFC9-02CB-4C94-AD81-0B482C6ADCBCQ36653754-79C12C70-08E3-417E-95F6-9E9C7397B444Q36783226-F10EC7EB-1CB8-42D6-AC1E-228A3534BBD9Q36807382-9EA1E3D6-C20E-4481-9350-BE25EFB6EE21Q37052988-4274D334-3C48-4F34-8800-8FFBF81A8AD7Q37091667-05CACF98-76C9-4868-A5D2-3261C4B98B12Q37442512-35508E96-CF0F-4BE7-AADF-14178A3D7DAFQ37603337-249E8376-D163-4E48-A626-A8BDCF66EE58Q38591644-B1150D4C-CA8C-4503-9B2B-25ABEE64A2B9Q38850833-EEC1B621-C661-4DAF-A2E3-7194D697FDEAQ38854793-D6A150D5-7A63-4D9F-A901-AF9F30FFDE03Q40225489-1C6DC1CD-358B-4820-A6D4-CD838080AA4BQ40346828-2C84D83F-F366-4D59-A7EE-6CA6671256FEQ41439274-A38D7F93-46D2-4B8A-9296-F1DCCB5C558DQ41997232-D4BB24EF-AE0C-461C-BD94-EEA033A34A34Q42697391-2658AD6B-A8BE-4A64-94A0-EDA8050E0CDBQ43103600-78C8C223-948D-4A75-8627-7B2FEEB38075Q46816304-A9CD8DDE-AD20-44EF-88FD-2789CB030BDDQ47278443-7AC70CAE-D5D1-49BC-965D-3C69109CDAACQ49391589-A88E644E-0574-4D9D-9FC4-9CF6B5CDB595Q50350456-6DD5C565-8109-4CF7-A176-F5A1DE135941Q53701991-6EDA9B88-D109-4704-983D-2801B0F9ECFAQ54268672-5FF8DBA1-31D5-4798-B056-F4BFD456F029Q54988367-B020193D-BD68-45A1-9C03-2D54CEE75BF8Q56911556-F1E2262B-CC3E-401B-BCF4-12C03DC6CDF3Q56912105-BFFDCD57-272C-42FD-A973-EDF88F976070Q57989945-A997E818-8926-4BE1-AE8B-F45A5B6785B2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nathan C Bahr
@es
Nathan C Bahr
@nl
Nathan C Bahr
@sl
Nathan C. Bahr
@en
type
label
Nathan C Bahr
@es
Nathan C Bahr
@nl
Nathan C Bahr
@sl
Nathan C. Bahr
@en
prefLabel
Nathan C Bahr
@es
Nathan C Bahr
@nl
Nathan C Bahr
@sl
Nathan C. Bahr
@en
P106
P1153
55978509700
P21
P31
P496
0000-0002-9431-8938
P569
2000-01-01T00:00:00Z